Skip to main content
Log in

Role of proficiency testing in monitoring of standardization of hemoglobin A1c methods

  • Practitioner's Report
  • Published:
Accreditation and Quality Assurance Aims and scope Submit manuscript

Abstract

After Hemoglobin A1c (HbA1c), therapeutic targets for monitoring diabetes therapy were recommended, first, National Glycohemoglobin Standardization Program (NGSP), then, the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) developed standardization initiatives. The aim of this article is to demonstrate the role of a proficiency testing (PT) programs in monitoring the long-term effect of these initiatives and the current status of HbA1c measurement. Measurement precision as a coefficient of variation (CV), measurement bias (bias), and satisfactory HbA1c result rates in proficiency testing (PT) surveys were evaluated using fresh single donor whole blood PT items and assigned values from a NGSP-certified secondary reference laboratory. Between 2000 and 2010, both CV and bias of the IC measurement method showed a decreasing trend. While the CV of the HPLC measurement method decreased, no significant change was observed in its bias. The rates of satisfactory HbA1c results in PT surveys were higher in HPLC users than IC users. In 2010, the average CVs in HPLC and IC groups were 2.6 and 3.4 %, biases were 2.7 and 1.8 %, and corresponding total error (TE) estimates were 7.8 and 8.5 %, respectively. These TE values were higher than the maximum permissible measurement error of 7 %, developed based on clinical use of the test. The NGSP and the IFCC networks have promoted improvements in HbA1c testing; however, tightening of NGSP method certification criteria seems to be necessary to achieve a maximum permissible measurement error of 7 %.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Little RR, Rohlfing CL, Sacks DB, National Glycohemoglobin Standardization Program (NGSP) Steering Committee (2011) Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care. Clin Chem 57:205–214

    Article  CAS  Google Scholar 

  2. Steffes M, Cleary P, Goldstein D, Little R, Wiedmeyer HM, Rohlfing C, England J, Bucksa J, Nowicki M (2005) Hemoglobin A1c measurements over nearly two decades: sustaining comparable values throughout the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study. Clin Chem 51:753–758

    Article  CAS  Google Scholar 

  3. Kaiser P, Akerboom T, Ohlendorf R, Reinauer H (2010) Liquid chromatography-isotope dilution-mass spectrometry as a new basis for the reference measurement procedure for hemoglobin A1c determination. Clin Chem 56:750–754

    Article  CAS  Google Scholar 

  4. Sacks DB for the ADA/EASD/IDF working group of the HbA1c Assay (2005) Global harmonization of hemoglobin A1c. Clin Chem 51:681–683

    Article  Google Scholar 

  5. Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I, Hoshino T, John WG, Kobold U, Little R, Mosca A, Mauri P, Paroni R, Susanto F, Takei I, Thienpont L, Umemoto M, Wiedmeyer HM, IFCC Working Group on HbA1c Standardization (2004) IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 50:166–174

    Article  CAS  Google Scholar 

  6. Geistanger A, Arends S, Berding C, Hoshino T, Jeppsson JO, Little R, Siebelder C, Weykamp C, IFCC Working Group on Standardization of Hemoglobin A1c (2008) Statistical methods for monitoring the relationship between the IFCC reference measurement procedure for hemoglobin A1c and the designated comparison methods in the United States, Japan, and Sweden. Clin Chem 54:1379–1385

    Article  CAS  Google Scholar 

  7. Hanas R, John G, International HbA Consensus Committee (2010) 2010 consensus statement on the worldwide standardization of the hemoglobin A1c measurement. Pediatric Diabetes 11:209–211

    Article  Google Scholar 

  8. Little RR, Rohlfing CL, Wiedmeyer HM, Myers GL, Sacks DB, Goldstein DE, NGSP Steering Committee (2001) The national glycohemoglobin standardization program: a five-year progress report. Clin Chem 47:1985–1992

    CAS  Google Scholar 

  9. Weykamp C, John WG, Mosca A, Hoshino T, Little R, Jeppsson JO, Goodall I, Miedema K, Myers G, Reinauer H, Sacks DB, Slingerland R, Siebelder C (2008) The IFCC reference measurement system for HbA1c: a 6-year progress report. Clin Chem 54:240–248

    Article  CAS  Google Scholar 

  10. Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvart AR, Kirkman MS, Lernmark A, Metzger BE, Nathan DM (2011) Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 57(6):e1–e147

    Article  Google Scholar 

  11. ISO 13528:2005(E), Statistical methods for use in proficiency testing by interlaboratory comparisons (2005) International Organization for Standardization, Geneva

  12. Westgard JO (2002) Basic QC practices. Westgard QC Inc, Madison, WI

    Google Scholar 

  13. NGSP Certified Methods (2011) http://www.ngsp.org/docs/methods.pdf. Accessed June 2011

  14. American Diabetes Association Standards of medical care in diabetes 2011 (2011) Diabetes Care 34(Suppl 1):S11–S61

    Article  Google Scholar 

  15. American Diabetes Association Standards of medical care in diabetes 2010 (2010) Diabetes Care 33(Suppl 1):S11–S61

    Article  Google Scholar 

  16. Fraser CG (2001) Biological variation: from principles to practice. AACC Press, Washington, DC

    Google Scholar 

  17. Biological Variation Database Specifications 2010 update of Ricos C, Alvarez V, Cava F, Garcia-Lario JV, Hernandez A, Jimenez CV, Minchinela J, Perich C, Simon M. (1999) “Current databases on biologic variation: pros, cons and progress.” Scand J Clin Lab Invest 59:491–500. http://www.westgard.com/biodatabase1.htm. Accessed August 2011

    Google Scholar 

  18. Kilpatrick ES, Maylor PW, Keevil BG (1998) Biological variation of glycated hemoglobin. Implications for diabetes screening and monitoring. Diabetes Care 21:261–264

    Article  CAS  Google Scholar 

  19. Garde AH, Hansen AM, Skovgaard LT, Christensen JM (2000) Seasonal and biological variation of blood concentrations of total cholesterol, dehydroepiandrosterone sulfate, hemoglobin A(1c), IgA, prolactin, and free testosterone in healthy women. Clin Chem 46:551–559

    CAS  Google Scholar 

  20. Rohlfing C, Wiedmeyer HM, Little R, Grotz VL, Tennill A, England J, Madsen R, Goldstein D (2002) Biological variation of glycohemoglobin. Clin Chem 48:1116–1118

    CAS  Google Scholar 

  21. Phillipou G, Phillips PJ (1993) Intraindividual variation of glycohemoglobin: implications for interpretation and analytical goals. Clin Chem 39:2305–2308

    CAS  Google Scholar 

  22. Friedecký B, Kratochvíla J, Budina M, Šperligová I (2010) The results of HbA1c measurement and its comparison with reference method values in an EQA programme. Accred Qual Assur 15:239–243

    Article  Google Scholar 

  23. Sofronescu AG, Williams LM, Andrews DM, Zhu Y (2011) Unexpected hemoglobin A1c results. Clin Chem 57:153–157

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Berna Aslan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aslan, B., Gun-Munro, J. & Flynn, G.J. Role of proficiency testing in monitoring of standardization of hemoglobin A1c methods. Accred Qual Assur 17, 419–424 (2012). https://doi.org/10.1007/s00769-012-0907-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00769-012-0907-1

Keywords

Navigation